Skip to main navigation Skip to search Skip to main content

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Confirm the Safety, Tolerability, and Efficacy of Zilucoplan in Subjects with Generalized Myasthenia Gravis

Project: Research

Project Details

StatusFinished
Effective start/end date11/21/19 → 11/21/22

Funding

  • Pharmaceutical Research Associates Incorporated: $31,500.00